Physician profile
Erol Onal
NPI 1083646848
$725.88
in general payments reported to CMS, 2019-2025
14 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.55 · 2021: $164 · 2022: $110 · 2023: $114 · 2024: $113 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $219.92 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $91.90 | 2023-2025 | Qelbree, Qelbree |
| Sobi, INC | $73.34 | 2021-2024 | |
| Cranial Technologies, INC | $50.68 | 2021-2024 | Doc Band |
| Pfizer INC. | $41.35 | 2023-2025 | |
| Tris Pharma INC | $39.64 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $39.06 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.64 | 2021 | |
| Adlon Therapeutics L.P. | $32.91 | 2021 | |
| Sanofi Pasteur INC. | $26.01 | 2021 | |
| Ironshore Pharmaceuticals INC. | $20.20 | 2019 | |
| Glaxosmithkline, LLC. | $19.60 | 2025 | Bexsero |
| Shire North American Group INC | $17.50 | 2019 | |
| Genentech USA, INC. | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erol Onal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.